Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1985 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1982 |
100 Clinical Results associated with Guangxi Hefeng Pharmaceutical Limited Liability Company
0 Patents (Medical) associated with Guangxi Hefeng Pharmaceutical Limited Liability Company
100 Deals associated with Guangxi Hefeng Pharmaceutical Limited Liability Company
100 Translational Medicine associated with Guangxi Hefeng Pharmaceutical Limited Liability Company